Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Iodide Peroxidase | 77 | 2011 | 295 | 7.910 |
Why?
|
Triiodothyronine | 44 | 2008 | 493 | 2.530 |
Why?
|
Thyroxine | 30 | 2006 | 665 | 1.350 |
Why?
|
Thyroid Hormones | 20 | 2008 | 408 | 1.350 |
Why?
|
Selenocysteine | 14 | 2000 | 127 | 1.090 |
Why?
|
Receptors, Thyroid Hormone | 17 | 2004 | 202 | 1.050 |
Why?
|
Thyroid Gland | 17 | 2005 | 1170 | 0.980 |
Why?
|
Hypothyroidism | 16 | 2006 | 665 | 0.780 |
Why?
|
RNA, Messenger | 29 | 2009 | 12791 | 0.570 |
Why?
|
Promoter Regions, Genetic | 23 | 2005 | 5789 | 0.560 |
Why?
|
Isoenzymes | 10 | 2004 | 1688 | 0.540 |
Why?
|
Molecular Sequence Data | 43 | 2008 | 17608 | 0.490 |
Why?
|
Thyrotoxicosis | 4 | 2004 | 85 | 0.490 |
Why?
|
Rats | 54 | 2010 | 23717 | 0.480 |
Why?
|
Cysteine | 9 | 2000 | 896 | 0.470 |
Why?
|
Selenium | 8 | 2001 | 418 | 0.450 |
Why?
|
Growth Hormone | 10 | 2001 | 572 | 0.430 |
Why?
|
Base Sequence | 33 | 2002 | 12415 | 0.410 |
Why?
|
Receptors, Cytoplasmic and Nuclear | 3 | 2005 | 857 | 0.370 |
Why?
|
Eating | 4 | 2010 | 1539 | 0.360 |
Why?
|
Cyclic AMP | 7 | 2004 | 1472 | 0.340 |
Why?
|
Pituitary Gland | 6 | 2009 | 635 | 0.340 |
Why?
|
Adipose Tissue, Brown | 6 | 2001 | 776 | 0.310 |
Why?
|
Obesity | 10 | 2011 | 13090 | 0.310 |
Why?
|
Cysteine Endopeptidases | 3 | 2000 | 542 | 0.310 |
Why?
|
Amino Acid Sequence | 23 | 2008 | 13411 | 0.290 |
Why?
|
Codon | 4 | 1993 | 599 | 0.290 |
Why?
|
Gene Expression | 14 | 2003 | 7585 | 0.290 |
Why?
|
Propylthiouracil | 9 | 2002 | 68 | 0.290 |
Why?
|
Iodine Radioisotopes | 5 | 2005 | 1030 | 0.290 |
Why?
|
Multienzyme Complexes | 3 | 2000 | 663 | 0.290 |
Why?
|
Genomic Imprinting | 1 | 2009 | 326 | 0.290 |
Why?
|
Thyrotropin | 14 | 2009 | 834 | 0.280 |
Why?
|
Iodine | 4 | 2001 | 285 | 0.280 |
Why?
|
Transfection | 23 | 2008 | 5754 | 0.280 |
Why?
|
Kinetics | 15 | 2004 | 6287 | 0.270 |
Why?
|
Hyperthyroidism | 4 | 1999 | 292 | 0.270 |
Why?
|
Protein Biosynthesis | 6 | 2002 | 2093 | 0.260 |
Why?
|
Cloning, Molecular | 11 | 2003 | 4168 | 0.250 |
Why?
|
Transcription Factors | 8 | 2005 | 12150 | 0.250 |
Why?
|
Animals | 86 | 2011 | 168930 | 0.250 |
Why?
|
Peptide YY | 1 | 2006 | 135 | 0.250 |
Why?
|
Down-Regulation | 2 | 2004 | 2931 | 0.240 |
Why?
|
Muscle Proteins | 2 | 2001 | 1160 | 0.240 |
Why?
|
Receptors, Adrenergic | 1 | 2004 | 155 | 0.230 |
Why?
|
Arteriosclerosis | 2 | 2005 | 1055 | 0.220 |
Why?
|
Receptors, Adrenergic, beta | 1 | 2004 | 243 | 0.210 |
Why?
|
DNA, Complementary | 8 | 1999 | 1989 | 0.210 |
Why?
|
Adipose Tissue | 6 | 2011 | 3314 | 0.210 |
Why?
|
Response Elements | 1 | 2004 | 308 | 0.210 |
Why?
|
Placenta | 4 | 2003 | 1725 | 0.210 |
Why?
|
Pituitary Neoplasms | 5 | 1998 | 1324 | 0.200 |
Why?
|
Leptin | 2 | 2010 | 1596 | 0.200 |
Why?
|
Insulin Resistance | 6 | 2011 | 3989 | 0.200 |
Why?
|
5' Untranslated Regions | 2 | 2002 | 255 | 0.200 |
Why?
|
Methimazole | 4 | 2002 | 41 | 0.190 |
Why?
|
Gene Expression Regulation, Enzymologic | 5 | 2002 | 1168 | 0.190 |
Why?
|
Pregnancy Complications | 5 | 2004 | 2971 | 0.190 |
Why?
|
Cell Line | 20 | 2005 | 15563 | 0.190 |
Why?
|
Adrenergic alpha-Agonists | 3 | 1991 | 177 | 0.190 |
Why?
|
Thyroid Nodule | 6 | 2007 | 765 | 0.190 |
Why?
|
Heart | 3 | 2004 | 4425 | 0.190 |
Why?
|
Liver | 12 | 2011 | 7571 | 0.180 |
Why?
|
Proteins | 6 | 2005 | 6002 | 0.180 |
Why?
|
Vascular Neoplasms | 1 | 2002 | 167 | 0.180 |
Why?
|
Myocardium | 4 | 2004 | 4765 | 0.180 |
Why?
|
Transcription, Genetic | 9 | 2005 | 7609 | 0.180 |
Why?
|
Catalysis | 6 | 2008 | 767 | 0.180 |
Why?
|
Ion Channels | 3 | 2001 | 1043 | 0.180 |
Why?
|
Consensus Sequence | 5 | 1999 | 363 | 0.170 |
Why?
|
Thiazolidinediones | 1 | 2003 | 460 | 0.170 |
Why?
|
Rats, Sprague-Dawley | 11 | 2010 | 8106 | 0.170 |
Why?
|
Graves Disease | 1 | 2002 | 239 | 0.170 |
Why?
|
Blotting, Northern | 6 | 1999 | 1550 | 0.170 |
Why?
|
Endocrinology | 2 | 1997 | 441 | 0.170 |
Why?
|
RNA Processing, Post-Transcriptional | 1 | 2002 | 393 | 0.170 |
Why?
|
Hemangioma | 2 | 2005 | 727 | 0.160 |
Why?
|
Hormones | 3 | 2003 | 866 | 0.160 |
Why?
|
Organoselenium Compounds | 2 | 1996 | 21 | 0.160 |
Why?
|
Triiodothyronine, Reverse | 5 | 2000 | 22 | 0.160 |
Why?
|
Antithyroid Agents | 2 | 2002 | 72 | 0.160 |
Why?
|
Repetitive Sequences, Nucleic Acid | 6 | 1998 | 781 | 0.160 |
Why?
|
Uterus | 1 | 2003 | 661 | 0.160 |
Why?
|
Energy Metabolism | 3 | 2009 | 2903 | 0.160 |
Why?
|
Membrane Proteins | 4 | 2009 | 7868 | 0.160 |
Why?
|
Sequence Homology, Amino Acid | 7 | 2008 | 2746 | 0.150 |
Why?
|
Binding Sites | 11 | 2003 | 6012 | 0.150 |
Why?
|
NADH, NADPH Oxidoreductases | 1 | 1998 | 96 | 0.150 |
Why?
|
Acclimatization | 1 | 1998 | 113 | 0.150 |
Why?
|
Aurothioglucose | 2 | 1995 | 11 | 0.150 |
Why?
|
Genes | 4 | 1996 | 1824 | 0.150 |
Why?
|
Estradiol | 4 | 2005 | 1947 | 0.140 |
Why?
|
Transforming Growth Factor beta | 1 | 2005 | 1996 | 0.140 |
Why?
|
Up-Regulation | 2 | 2009 | 4142 | 0.140 |
Why?
|
Nerve Tissue Proteins | 2 | 2009 | 4400 | 0.140 |
Why?
|
Nucleic Acid Conformation | 5 | 2002 | 899 | 0.140 |
Why?
|
Alternative Splicing | 1 | 2002 | 1103 | 0.140 |
Why?
|
Body Weight | 3 | 2009 | 4626 | 0.140 |
Why?
|
Body Temperature Regulation | 1 | 1998 | 292 | 0.140 |
Why?
|
DNA Transposable Elements | 2 | 2002 | 764 | 0.140 |
Why?
|
DNA | 12 | 2001 | 7208 | 0.140 |
Why?
|
Rats, Inbred Strains | 7 | 1991 | 2078 | 0.140 |
Why?
|
Cycloheximide | 5 | 2003 | 340 | 0.130 |
Why?
|
Conserved Sequence | 4 | 2005 | 1159 | 0.130 |
Why?
|
Thyroid Diseases | 4 | 1994 | 385 | 0.130 |
Why?
|
Endopeptidases | 1 | 2000 | 762 | 0.130 |
Why?
|
Insulin | 4 | 2010 | 6608 | 0.130 |
Why?
|
Thyroid Function Tests | 3 | 1995 | 289 | 0.130 |
Why?
|
Gold Sodium Thiomalate | 1 | 1995 | 10 | 0.130 |
Why?
|
Rats, Wistar | 3 | 2009 | 1889 | 0.120 |
Why?
|
Blood Glucose | 7 | 2010 | 6422 | 0.120 |
Why?
|
Fetus | 1 | 2003 | 1878 | 0.120 |
Why?
|
Structure-Activity Relationship | 8 | 2003 | 3053 | 0.120 |
Why?
|
Animal Nutritional Physiological Phenomena | 1 | 1995 | 54 | 0.120 |
Why?
|
Affinity Labels | 2 | 1992 | 107 | 0.120 |
Why?
|
Hypothalamus | 3 | 2009 | 1003 | 0.120 |
Why?
|
Cold Temperature | 1 | 1998 | 794 | 0.120 |
Why?
|
Tumor Cells, Cultured | 8 | 2001 | 6104 | 0.120 |
Why?
|
Dimerization | 3 | 2008 | 882 | 0.120 |
Why?
|
Luciferases | 1 | 1996 | 713 | 0.120 |
Why?
|
Models, Chemical | 3 | 2005 | 607 | 0.120 |
Why?
|
Mutagenesis, Site-Directed | 7 | 2003 | 1677 | 0.120 |
Why?
|
Mutagenesis | 4 | 2000 | 1228 | 0.120 |
Why?
|
Chickens | 4 | 2002 | 842 | 0.120 |
Why?
|
Adaptation, Physiological | 1 | 2001 | 1313 | 0.110 |
Why?
|
RNA, Transfer, Amino Acid-Specific | 1 | 1993 | 24 | 0.110 |
Why?
|
Pituitary Gland, Anterior | 3 | 2003 | 142 | 0.110 |
Why?
|
Central Nervous System | 1 | 2001 | 1345 | 0.110 |
Why?
|
Chloramphenicol O-Acetyltransferase | 4 | 2000 | 220 | 0.110 |
Why?
|
Skin Abnormalities | 1 | 1994 | 60 | 0.110 |
Why?
|
Gene Expression Regulation | 7 | 2006 | 11920 | 0.110 |
Why?
|
DNA Primers | 4 | 2000 | 2826 | 0.110 |
Why?
|
Plasmids | 6 | 2000 | 2268 | 0.110 |
Why?
|
Thyroid Neoplasms | 6 | 2006 | 2355 | 0.110 |
Why?
|
Nuclear Proteins | 4 | 2004 | 5795 | 0.110 |
Why?
|
In Situ Hybridization | 5 | 2006 | 1892 | 0.110 |
Why?
|
Cells, Cultured | 11 | 2008 | 18984 | 0.100 |
Why?
|
Organ Size | 3 | 2003 | 2261 | 0.100 |
Why?
|
Awards and Prizes | 1 | 1997 | 365 | 0.100 |
Why?
|
Regulatory Sequences, Nucleic Acid | 1 | 1996 | 792 | 0.100 |
Why?
|
Genes, Reporter | 1 | 1996 | 1525 | 0.100 |
Why?
|
Humans | 76 | 2009 | 766766 | 0.100 |
Why?
|
Half-Life | 3 | 2002 | 648 | 0.100 |
Why?
|
Selenoproteins | 4 | 2002 | 216 | 0.100 |
Why?
|
Glucose Tolerance Test | 4 | 2011 | 1180 | 0.100 |
Why?
|
Mutation | 14 | 2004 | 30213 | 0.090 |
Why?
|
Sequence Alignment | 4 | 1997 | 2177 | 0.090 |
Why?
|
Diet | 5 | 2011 | 8088 | 0.090 |
Why?
|
Codon, Initiator | 2 | 2002 | 50 | 0.090 |
Why?
|
Protein Synthesis Inhibitors | 3 | 2001 | 187 | 0.090 |
Why?
|
Dexamethasone | 4 | 2001 | 1962 | 0.090 |
Why?
|
Polymorphism, Genetic | 3 | 2008 | 4249 | 0.090 |
Why?
|
Selenium Radioisotopes | 3 | 2003 | 13 | 0.090 |
Why?
|
Kidney Tubules, Proximal | 1 | 1993 | 386 | 0.090 |
Why?
|
8-Bromo Cyclic Adenosine Monophosphate | 3 | 1998 | 73 | 0.090 |
Why?
|
Endoplasmic Reticulum | 4 | 2005 | 1132 | 0.090 |
Why?
|
Mice, Inbred Strains | 1 | 1993 | 1767 | 0.090 |
Why?
|
Thyrotropin-Releasing Hormone | 3 | 1998 | 139 | 0.090 |
Why?
|
Mice | 17 | 2011 | 81889 | 0.090 |
Why?
|
Biogenic Monoamines | 1 | 2010 | 50 | 0.090 |
Why?
|
DNA-Binding Proteins | 4 | 2001 | 9611 | 0.090 |
Why?
|
Biopsy, Needle | 3 | 2005 | 1615 | 0.080 |
Why?
|
PC12 Cells | 1 | 2009 | 317 | 0.080 |
Why?
|
Adenocarcinoma, Follicular | 2 | 2003 | 323 | 0.080 |
Why?
|
Calcium-Transporting ATPases | 2 | 2001 | 122 | 0.080 |
Why?
|
Mice, Obese | 1 | 2009 | 417 | 0.080 |
Why?
|
Homeostasis | 4 | 2009 | 3342 | 0.080 |
Why?
|
Male | 39 | 2011 | 364142 | 0.080 |
Why?
|
Mice, Inbred C57BL | 8 | 2011 | 22352 | 0.080 |
Why?
|
3' Untranslated Regions | 2 | 2002 | 515 | 0.080 |
Why?
|
Tretinoin | 3 | 1998 | 524 | 0.070 |
Why?
|
Recombinant Proteins | 7 | 2003 | 6507 | 0.070 |
Why?
|
Ubiquitins | 2 | 2000 | 365 | 0.070 |
Why?
|
Amino Acids | 1 | 1994 | 1711 | 0.070 |
Why?
|
Adrenergic beta-Agonists | 1 | 1989 | 345 | 0.070 |
Why?
|
Mice, Inbred C3H | 3 | 2006 | 915 | 0.070 |
Why?
|
Alanine | 2 | 2000 | 613 | 0.070 |
Why?
|
1-Methyl-3-isobutylxanthine | 2 | 1998 | 100 | 0.070 |
Why?
|
Potassium Channels | 2 | 2001 | 534 | 0.070 |
Why?
|
Protein Conformation | 1 | 1995 | 3947 | 0.070 |
Why?
|
Hormone Antagonists | 1 | 2007 | 109 | 0.070 |
Why?
|
Pancreas | 2 | 2009 | 1698 | 0.070 |
Why?
|
Dogs | 4 | 1997 | 3834 | 0.070 |
Why?
|
Gene Library | 2 | 2001 | 1065 | 0.070 |
Why?
|
Thioredoxins | 2 | 2005 | 202 | 0.070 |
Why?
|
Tetradecanoylphorbol Acetate | 1 | 1988 | 826 | 0.070 |
Why?
|
Microsomes | 3 | 1996 | 252 | 0.070 |
Why?
|
Bile Acids and Salts | 1 | 2009 | 398 | 0.070 |
Why?
|
Sp1 Transcription Factor | 2 | 1998 | 143 | 0.070 |
Why?
|
Neoplasm Proteins | 1 | 1998 | 3601 | 0.070 |
Why?
|
Tamoxifen | 1 | 1991 | 967 | 0.070 |
Why?
|
Kidney | 9 | 2004 | 7074 | 0.070 |
Why?
|
Genomic Library | 3 | 1996 | 189 | 0.060 |
Why?
|
Drug Administration Routes | 1 | 2006 | 152 | 0.060 |
Why?
|
Disulfides | 2 | 2005 | 462 | 0.060 |
Why?
|
Norepinephrine | 2 | 2004 | 898 | 0.060 |
Why?
|
Osmolar Concentration | 2 | 1997 | 655 | 0.060 |
Why?
|
Iduronidase | 1 | 2005 | 31 | 0.060 |
Why?
|
Drug Monitoring | 1 | 1992 | 962 | 0.060 |
Why?
|
Maternal-Fetal Exchange | 2 | 2001 | 453 | 0.060 |
Why?
|
Biopsy, Fine-Needle | 2 | 2007 | 1131 | 0.060 |
Why?
|
Cell Membrane | 3 | 2004 | 3641 | 0.060 |
Why?
|
Dithiothreitol | 3 | 2003 | 94 | 0.060 |
Why?
|
Mice, Transgenic | 5 | 2007 | 9547 | 0.060 |
Why?
|
Oxygen Consumption | 1 | 1991 | 1874 | 0.060 |
Why?
|
Introns | 2 | 2000 | 966 | 0.060 |
Why?
|
Xenobiotics | 1 | 2005 | 71 | 0.060 |
Why?
|
Smad Proteins | 1 | 2005 | 157 | 0.060 |
Why?
|
Taste | 1 | 2006 | 190 | 0.060 |
Why?
|
Proteasome Endopeptidase Complex | 3 | 2000 | 1319 | 0.060 |
Why?
|
DNA Footprinting | 1 | 2004 | 97 | 0.060 |
Why?
|
Rodentia | 1 | 2006 | 262 | 0.060 |
Why?
|
Muscle Cells | 1 | 2005 | 194 | 0.060 |
Why?
|
Phenytoin | 1 | 2005 | 189 | 0.060 |
Why?
|
Liver Neoplasms | 1 | 2000 | 4353 | 0.060 |
Why?
|
Organ Specificity | 4 | 1997 | 1966 | 0.060 |
Why?
|
Receptors, Steroid | 1 | 2005 | 157 | 0.060 |
Why?
|
Hypothalamus, Middle | 1 | 2003 | 15 | 0.060 |
Why?
|
Phenobarbital | 1 | 2005 | 192 | 0.060 |
Why?
|
Protein Folding | 2 | 2005 | 868 | 0.060 |
Why?
|
Electrophoretic Mobility Shift Assay | 1 | 2004 | 294 | 0.060 |
Why?
|
Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2008 | 627 | 0.060 |
Why?
|
Rats, Mutant Strains | 1 | 2003 | 60 | 0.060 |
Why?
|
Muscle, Skeletal | 3 | 2005 | 4970 | 0.050 |
Why?
|
Adiponectin | 2 | 2009 | 1121 | 0.050 |
Why?
|
Phenylpropionates | 1 | 2003 | 34 | 0.050 |
Why?
|
Prediabetic State | 1 | 2009 | 547 | 0.050 |
Why?
|
Xenopus | 2 | 1998 | 710 | 0.050 |
Why?
|
Polymorphism, Restriction Fragment Length | 2 | 1995 | 766 | 0.050 |
Why?
|
Protein Kinase C | 1 | 1988 | 1206 | 0.050 |
Why?
|
Triglycerides | 2 | 2009 | 2441 | 0.050 |
Why?
|
Fenofibrate | 1 | 2003 | 87 | 0.050 |
Why?
|
Sex Hormone-Binding Globulin | 1 | 2005 | 557 | 0.050 |
Why?
|
Keratinocytes | 1 | 2007 | 876 | 0.050 |
Why?
|
Histocytochemistry | 2 | 2006 | 697 | 0.050 |
Why?
|
Hedgehog Proteins | 1 | 2007 | 771 | 0.050 |
Why?
|
Ubiquitin-Conjugating Enzymes | 1 | 2003 | 196 | 0.050 |
Why?
|
Aorta, Abdominal | 1 | 2005 | 627 | 0.050 |
Why?
|
Societies, Medical | 1 | 1995 | 3957 | 0.050 |
Why?
|
Aortic Diseases | 2 | 2005 | 741 | 0.050 |
Why?
|
Chorionic Gonadotropin | 1 | 2004 | 458 | 0.050 |
Why?
|
Absorptiometry, Photon | 2 | 2005 | 1707 | 0.050 |
Why?
|
Trans-Activators | 3 | 2007 | 2855 | 0.050 |
Why?
|
Insulin-Secreting Cells | 1 | 2009 | 899 | 0.050 |
Why?
|
Ultrasonography | 5 | 2007 | 5992 | 0.050 |
Why?
|
Macromolecular Substances | 2 | 1996 | 1431 | 0.050 |
Why?
|
Umbilical Cord | 1 | 2003 | 178 | 0.050 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 3 | 2011 | 4570 | 0.050 |
Why?
|
Models, Molecular | 3 | 2008 | 5386 | 0.050 |
Why?
|
Oxazines | 1 | 2003 | 358 | 0.050 |
Why?
|
Glutathione Peroxidase | 2 | 1993 | 258 | 0.050 |
Why?
|
Molecular Structure | 1 | 2005 | 1882 | 0.050 |
Why?
|
Pregnancy | 7 | 2004 | 30237 | 0.050 |
Why?
|
Chick Embryo | 2 | 2001 | 972 | 0.050 |
Why?
|
Immunohistochemistry | 5 | 2006 | 11061 | 0.050 |
Why?
|
Adenine Nucleotides | 1 | 2001 | 111 | 0.050 |
Why?
|
Anthropometry | 1 | 2005 | 1336 | 0.040 |
Why?
|
Gastrointestinal Stromal Tumors | 1 | 2006 | 616 | 0.040 |
Why?
|
Female | 25 | 2009 | 396520 | 0.040 |
Why?
|
Sequence Homology | 1 | 2001 | 197 | 0.040 |
Why?
|
Epithelium | 1 | 2005 | 1606 | 0.040 |
Why?
|
Disease Models, Animal | 3 | 2010 | 18330 | 0.040 |
Why?
|
Gastric Bypass | 1 | 2009 | 820 | 0.040 |
Why?
|
Exopeptidases | 1 | 2000 | 1 | 0.040 |
Why?
|
Ubiquitin | 1 | 2005 | 841 | 0.040 |
Why?
|
Pyrroles | 1 | 2006 | 1121 | 0.040 |
Why?
|
Sarcoplasmic Reticulum Calcium-Transporting ATPases | 1 | 2001 | 132 | 0.040 |
Why?
|
DNA Mutational Analysis | 3 | 1994 | 4114 | 0.040 |
Why?
|
Weight Loss | 2 | 2010 | 2712 | 0.040 |
Why?
|
Ependyma | 1 | 2000 | 57 | 0.040 |
Why?
|
Retreatment | 1 | 2002 | 598 | 0.040 |
Why?
|
Endometrium | 1 | 2003 | 406 | 0.040 |
Why?
|
Paired Box Transcription Factors | 1 | 2001 | 205 | 0.040 |
Why?
|
Dose-Response Relationship, Radiation | 1 | 2002 | 877 | 0.040 |
Why?
|
Cyclobutanes | 2 | 2010 | 57 | 0.040 |
Why?
|
Drug Administration Schedule | 2 | 2006 | 4853 | 0.040 |
Why?
|
Acetylcysteine | 1 | 2001 | 262 | 0.040 |
Why?
|
Binding, Competitive | 2 | 1991 | 1141 | 0.040 |
Why?
|
TATA Box | 1 | 2000 | 127 | 0.040 |
Why?
|
Subcellular Fractions | 1 | 2000 | 526 | 0.040 |
Why?
|
GTP-Binding Proteins | 1 | 2004 | 946 | 0.040 |
Why?
|
Endosomes | 1 | 2002 | 521 | 0.040 |
Why?
|
Dactinomycin | 2 | 2001 | 304 | 0.040 |
Why?
|
Random Amplified Polymorphic DNA Technique | 1 | 1999 | 20 | 0.040 |
Why?
|
Glutathione | 2 | 2002 | 589 | 0.040 |
Why?
|
Brain | 5 | 2001 | 27159 | 0.040 |
Why?
|
Ranidae | 1 | 1999 | 32 | 0.040 |
Why?
|
Receptors, Retinoic Acid | 3 | 1995 | 229 | 0.040 |
Why?
|
GMP Reductase | 1 | 1998 | 3 | 0.040 |
Why?
|
Carbonyl Cyanide m-Chlorophenyl Hydrazone | 1 | 1998 | 22 | 0.040 |
Why?
|
Cytochalasin B | 1 | 1998 | 74 | 0.040 |
Why?
|
Ischemia | 1 | 2008 | 1905 | 0.040 |
Why?
|
Fluorescent Antibody Technique | 2 | 2000 | 2470 | 0.040 |
Why?
|
Indicators and Reagents | 1 | 2000 | 456 | 0.040 |
Why?
|
Myosin Heavy Chains | 1 | 2001 | 403 | 0.040 |
Why?
|
Uncoupling Agents | 1 | 1998 | 46 | 0.040 |
Why?
|
Xenopus laevis | 2 | 1995 | 965 | 0.040 |
Why?
|
Hypolipidemic Agents | 1 | 2003 | 609 | 0.040 |
Why?
|
Leupeptins | 1 | 1998 | 112 | 0.040 |
Why?
|
Creatine Kinase | 1 | 2001 | 683 | 0.040 |
Why?
|
Ligands | 2 | 1996 | 3275 | 0.040 |
Why?
|
Body Composition | 2 | 2005 | 2441 | 0.040 |
Why?
|
Cyclic AMP-Dependent Protein Kinases | 1 | 2001 | 482 | 0.040 |
Why?
|
Indoles | 1 | 2006 | 1834 | 0.040 |
Why?
|
Transcriptional Activation | 2 | 1996 | 1749 | 0.040 |
Why?
|
Intercellular Signaling Peptides and Proteins | 1 | 2005 | 1657 | 0.040 |
Why?
|
Chromosome Mapping | 3 | 1996 | 4619 | 0.040 |
Why?
|
Microscopy, Confocal | 2 | 2001 | 1969 | 0.040 |
Why?
|
Feeding Behavior | 2 | 2010 | 3208 | 0.040 |
Why?
|
Cysts | 1 | 2003 | 685 | 0.040 |
Why?
|
Cyclic AMP Response Element-Binding Protein | 1 | 2000 | 501 | 0.040 |
Why?
|
Protein-Tyrosine Kinases | 1 | 2006 | 2426 | 0.040 |
Why?
|
Chloroquine | 1 | 1998 | 276 | 0.040 |
Why?
|
Iopanoic Acid | 2 | 1991 | 20 | 0.040 |
Why?
|
Molecular Weight | 3 | 2003 | 2168 | 0.030 |
Why?
|
Lipids | 2 | 2010 | 3319 | 0.030 |
Why?
|
Models, Biological | 4 | 2005 | 9461 | 0.030 |
Why?
|
Gene Expression Profiling | 2 | 2011 | 9525 | 0.030 |
Why?
|
Transcription Factor Pit-1 | 1 | 1996 | 16 | 0.030 |
Why?
|
Carrier Proteins | 3 | 1998 | 4924 | 0.030 |
Why?
|
Glucagon-Like Peptide 1 | 2 | 2010 | 374 | 0.030 |
Why?
|
Sulfuric Acid Esters | 1 | 1996 | 33 | 0.030 |
Why?
|
Electrophysiology | 1 | 1999 | 1263 | 0.030 |
Why?
|
Drug Synergism | 2 | 1991 | 1756 | 0.030 |
Why?
|
Sarcoplasmic Reticulum | 1 | 1996 | 164 | 0.030 |
Why?
|
Species Specificity | 1 | 2001 | 2413 | 0.030 |
Why?
|
Postmenopause | 1 | 2005 | 2517 | 0.030 |
Why?
|
Neoplasms, Multiple Primary | 1 | 2000 | 594 | 0.030 |
Why?
|
Substrate Specificity | 2 | 1997 | 1750 | 0.030 |
Why?
|
Isomerism | 1 | 1996 | 197 | 0.030 |
Why?
|
Oligonucleotide Probes | 1 | 1996 | 416 | 0.030 |
Why?
|
Motor Activity | 1 | 2006 | 2711 | 0.030 |
Why?
|
Thiazoles | 1 | 2003 | 1529 | 0.030 |
Why?
|
Lipopolysaccharides | 1 | 2003 | 2214 | 0.030 |
Why?
|
Gene Rearrangement | 2 | 2003 | 1142 | 0.030 |
Why?
|
Retinoid X Receptors | 1 | 1995 | 91 | 0.030 |
Why?
|
Deoxyribonuclease I | 1 | 1996 | 228 | 0.030 |
Why?
|
Enzyme Induction | 2 | 2008 | 455 | 0.030 |
Why?
|
Myocytes, Cardiac | 1 | 2004 | 1673 | 0.030 |
Why?
|
Mesothelioma | 1 | 2001 | 774 | 0.030 |
Why?
|
Protease Inhibitors | 1 | 1998 | 750 | 0.030 |
Why?
|
Genotype | 1 | 2009 | 13036 | 0.030 |
Why?
|
Carcinoma | 1 | 2006 | 2324 | 0.030 |
Why?
|
Restriction Mapping | 1 | 1995 | 848 | 0.030 |
Why?
|
Fibroblasts | 1 | 2005 | 4166 | 0.030 |
Why?
|
Cell-Free System | 1 | 1995 | 339 | 0.030 |
Why?
|
Adult | 12 | 2009 | 223307 | 0.030 |
Why?
|
Malate Dehydrogenase | 1 | 1993 | 40 | 0.030 |
Why?
|
Body Mass Index | 3 | 2009 | 13050 | 0.030 |
Why?
|
Selenoprotein P | 1 | 1993 | 33 | 0.030 |
Why?
|
Hypoglycemic Agents | 2 | 2003 | 3108 | 0.030 |
Why?
|
Microsomes, Liver | 1 | 1993 | 174 | 0.030 |
Why?
|
Peptide Fragments | 1 | 2006 | 5143 | 0.030 |
Why?
|
Muramidase | 1 | 1993 | 163 | 0.030 |
Why?
|
RNA Probes | 1 | 1993 | 110 | 0.030 |
Why?
|
Teratogens | 1 | 1994 | 119 | 0.030 |
Why?
|
Kidney Cortex | 1 | 1993 | 167 | 0.030 |
Why?
|
Weight Gain | 1 | 2003 | 2356 | 0.030 |
Why?
|
Kidney Medulla | 1 | 1993 | 169 | 0.030 |
Why?
|
Histidine | 1 | 1993 | 301 | 0.030 |
Why?
|
Mitochondrial Proteins | 1 | 1998 | 980 | 0.030 |
Why?
|
Molecular Biology | 1 | 1996 | 573 | 0.030 |
Why?
|
Eukaryotic Cells | 1 | 1993 | 192 | 0.030 |
Why?
|
Adenosine Triphosphate | 1 | 1998 | 2001 | 0.020 |
Why?
|
Congenital Hypothyroidism | 1 | 1992 | 40 | 0.020 |
Why?
|
Mice, Mutant Strains | 1 | 1995 | 1751 | 0.020 |
Why?
|
Proto-Oncogene Proteins | 3 | 1989 | 4522 | 0.020 |
Why?
|
Arthritis, Psoriatic | 1 | 1995 | 219 | 0.020 |
Why?
|
Actins | 1 | 1999 | 2060 | 0.020 |
Why?
|
Diazonium Compounds | 1 | 1991 | 17 | 0.020 |
Why?
|
Heart Ventricles | 1 | 2004 | 3832 | 0.020 |
Why?
|
Proline | 1 | 1993 | 454 | 0.020 |
Why?
|
Mammals | 1 | 1997 | 1133 | 0.020 |
Why?
|
Phenotype | 2 | 2009 | 16724 | 0.020 |
Why?
|
Electrophoresis, Polyacrylamide Gel | 3 | 2003 | 1729 | 0.020 |
Why?
|
Cell Line, Transformed | 1 | 1992 | 861 | 0.020 |
Why?
|
Heart Diseases | 1 | 2004 | 2817 | 0.020 |
Why?
|
Phosphoproteins | 1 | 2000 | 2448 | 0.020 |
Why?
|
Photochemistry | 1 | 1991 | 238 | 0.020 |
Why?
|
Chromosome Inversion | 1 | 1991 | 119 | 0.020 |
Why?
|
Point Mutation | 1 | 1996 | 1591 | 0.020 |
Why?
|
Abnormalities, Drug-Induced | 1 | 1994 | 337 | 0.020 |
Why?
|
Diabetes Mellitus | 1 | 2009 | 5887 | 0.020 |
Why?
|
Propionates | 1 | 1991 | 180 | 0.020 |
Why?
|
Reticulocytes | 1 | 1991 | 287 | 0.020 |
Why?
|
Sequence Analysis, DNA | 2 | 2007 | 4780 | 0.020 |
Why?
|
Blotting, Southern | 1 | 1991 | 774 | 0.020 |
Why?
|
Oligodeoxyribonucleotides | 1 | 1992 | 705 | 0.020 |
Why?
|
Gene Transfer Techniques | 1 | 1995 | 1206 | 0.020 |
Why?
|
Neurotransmitter Uptake Inhibitors | 1 | 2010 | 36 | 0.020 |
Why?
|
Cytokines | 1 | 2005 | 7438 | 0.020 |
Why?
|
Sequence Homology, Nucleic Acid | 1 | 1991 | 1057 | 0.020 |
Why?
|
Gene Expression Regulation, Developmental | 1 | 2001 | 3609 | 0.020 |
Why?
|
Drug Resistance | 1 | 1996 | 1592 | 0.020 |
Why?
|
Alprenolol | 1 | 1989 | 8 | 0.020 |
Why?
|
Bucladesine | 1 | 1989 | 118 | 0.020 |
Why?
|
Polymorphism, Single Nucleotide | 1 | 2009 | 16044 | 0.020 |
Why?
|
Prazosin | 1 | 1989 | 95 | 0.020 |
Why?
|
Yohimbine | 1 | 1989 | 63 | 0.020 |
Why?
|
Protein Binding | 2 | 2008 | 9320 | 0.020 |
Why?
|
Appetite Depressants | 1 | 2010 | 108 | 0.020 |
Why?
|
Enzyme Activation | 2 | 2000 | 3587 | 0.020 |
Why?
|
Saccharomyces cerevisiae Proteins | 1 | 1999 | 1836 | 0.020 |
Why?
|
Isoproterenol | 1 | 1989 | 398 | 0.020 |
Why?
|
Exons | 1 | 1995 | 2392 | 0.020 |
Why?
|
Signal Transduction | 2 | 2009 | 23619 | 0.020 |
Why?
|
Retrospective Studies | 7 | 2006 | 81635 | 0.020 |
Why?
|
Adenoma | 1 | 2000 | 2155 | 0.020 |
Why?
|
Phenylephrine | 1 | 1989 | 292 | 0.020 |
Why?
|
Tissue Distribution | 1 | 1993 | 2275 | 0.020 |
Why?
|
Reference Values | 1 | 1996 | 4913 | 0.020 |
Why?
|
Protein Structure, Tertiary | 2 | 2008 | 3757 | 0.020 |
Why?
|
History, 20th Century | 1 | 1997 | 2764 | 0.020 |
Why?
|
Prospective Studies | 3 | 2006 | 54871 | 0.020 |
Why?
|
Appetite | 1 | 2010 | 247 | 0.020 |
Why?
|
Genetic Linkage | 1 | 1993 | 2342 | 0.020 |
Why?
|
Skin Neoplasms | 1 | 2007 | 5861 | 0.020 |
Why?
|
Median Eminence | 1 | 1987 | 28 | 0.020 |
Why?
|
Hypertension | 1 | 2008 | 8616 | 0.020 |
Why?
|
Hypertrophy, Right Ventricular | 1 | 2008 | 109 | 0.020 |
Why?
|
Postprandial Period | 1 | 2009 | 320 | 0.020 |
Why?
|
Epithelial Cells | 1 | 1999 | 3691 | 0.020 |
Why?
|
Chromosome Deletion | 1 | 1991 | 1384 | 0.020 |
Why?
|
Cognition Disorders | 1 | 2001 | 3967 | 0.020 |
Why?
|
Muscles | 1 | 2011 | 1576 | 0.020 |
Why?
|
Thyroiditis | 1 | 2006 | 86 | 0.020 |
Why?
|
Middle Aged | 9 | 2009 | 223257 | 0.020 |
Why?
|
Predictive Value of Tests | 3 | 2007 | 15416 | 0.020 |
Why?
|
Enzyme Inhibitors | 1 | 1996 | 3721 | 0.020 |
Why?
|
Time Factors | 5 | 2010 | 40149 | 0.020 |
Why?
|
Benzofurans | 1 | 1986 | 139 | 0.020 |
Why?
|
Fluorescence Resonance Energy Transfer | 1 | 2008 | 415 | 0.020 |
Why?
|
Crosses, Genetic | 1 | 2006 | 752 | 0.020 |
Why?
|
Diabetes Mellitus, Type 2 | 2 | 2007 | 12245 | 0.020 |
Why?
|
Luminescent Proteins | 1 | 2008 | 839 | 0.020 |
Why?
|
Oocytes | 1 | 1990 | 1168 | 0.020 |
Why?
|
Surface Properties | 1 | 2008 | 1153 | 0.020 |
Why?
|
Feedback | 1 | 1989 | 797 | 0.010 |
Why?
|
Amiodarone | 1 | 1986 | 216 | 0.010 |
Why?
|
Enhancer Elements, Genetic | 1 | 1991 | 1363 | 0.010 |
Why?
|
RNA Splicing | 1 | 1989 | 903 | 0.010 |
Why?
|
Risk Factors | 3 | 2007 | 74881 | 0.010 |
Why?
|
Cytodiagnosis | 1 | 2007 | 450 | 0.010 |
Why?
|
Antineoplastic Agents | 1 | 2006 | 13643 | 0.010 |
Why?
|
Mice, Knockout | 2 | 2011 | 14471 | 0.010 |
Why?
|
Imidazoles | 1 | 1989 | 1168 | 0.010 |
Why?
|
Oncogene Proteins | 1 | 2007 | 715 | 0.010 |
Why?
|
Feedback, Physiological | 1 | 2006 | 481 | 0.010 |
Why?
|
Immunosorbent Techniques | 1 | 2003 | 174 | 0.010 |
Why?
|
Glycoside Hydrolases | 1 | 2003 | 135 | 0.010 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 1 | 2010 | 3804 | 0.010 |
Why?
|
Cattle | 1 | 1988 | 3815 | 0.010 |
Why?
|
Fasting | 1 | 2009 | 1609 | 0.010 |
Why?
|
Transcription Factor RelA | 1 | 2003 | 252 | 0.010 |
Why?
|
Neoplasm Recurrence, Local | 1 | 2000 | 9404 | 0.010 |
Why?
|
Child Development | 1 | 1994 | 2327 | 0.010 |
Why?
|
Thyroidectomy | 1 | 2007 | 912 | 0.010 |
Why?
|
Analysis of Variance | 1 | 2010 | 6214 | 0.010 |
Why?
|
Isotope Labeling | 1 | 2003 | 390 | 0.010 |
Why?
|
Sensitivity and Specificity | 2 | 2007 | 14652 | 0.010 |
Why?
|
Dioxoles | 1 | 2001 | 96 | 0.010 |
Why?
|
Piperidines | 1 | 2010 | 1663 | 0.010 |
Why?
|
Databases as Topic | 1 | 2003 | 472 | 0.010 |
Why?
|
Clathrin | 1 | 2002 | 258 | 0.010 |
Why?
|
Digitonin | 1 | 2000 | 25 | 0.010 |
Why?
|
Plant Proteins | 1 | 2003 | 375 | 0.010 |
Why?
|
Dopamine and cAMP-Regulated Phosphoprotein 32 | 1 | 2000 | 29 | 0.010 |
Why?
|
Sulfur Radioisotopes | 1 | 2000 | 113 | 0.010 |
Why?
|
Body Temperature | 1 | 2003 | 780 | 0.010 |
Why?
|
Palpation | 1 | 2000 | 166 | 0.010 |
Why?
|
Dose-Response Relationship, Drug | 2 | 2003 | 10745 | 0.010 |
Why?
|
Protein Structure, Secondary | 1 | 2003 | 1211 | 0.010 |
Why?
|
Diamide | 1 | 1979 | 18 | 0.010 |
Why?
|
Dinitrophenols | 1 | 1979 | 56 | 0.010 |
Why?
|
Treatment Outcome | 2 | 2009 | 65273 | 0.010 |
Why?
|
Gene Frequency | 1 | 2007 | 3624 | 0.010 |
Why?
|
Time | 1 | 2001 | 550 | 0.010 |
Why?
|
Escherichia coli | 1 | 1992 | 4211 | 0.010 |
Why?
|
Pyrazoles | 1 | 2010 | 2030 | 0.010 |
Why?
|
Arthritis, Rheumatoid | 1 | 1995 | 3788 | 0.010 |
Why?
|
Aneuploidy | 1 | 2003 | 573 | 0.010 |
Why?
|
Ligases | 1 | 2000 | 330 | 0.010 |
Why?
|
Cell Membrane Permeability | 1 | 2000 | 568 | 0.010 |
Why?
|
Radioimmunoassay | 1 | 1999 | 861 | 0.010 |
Why?
|
Infant, Newborn | 2 | 2001 | 26389 | 0.010 |
Why?
|
Precipitin Tests | 1 | 1999 | 816 | 0.010 |
Why?
|
Endocytosis | 1 | 2002 | 951 | 0.010 |
Why?
|
Infant | 1 | 2000 | 36461 | 0.010 |
Why?
|
Cerebral Cortex | 2 | 2004 | 5753 | 0.010 |
Why?
|
Electroporation | 1 | 1999 | 238 | 0.010 |
Why?
|
Heterozygote | 1 | 2004 | 2795 | 0.010 |
Why?
|
United States | 2 | 1997 | 72951 | 0.010 |
Why?
|
Case-Control Studies | 2 | 2009 | 22248 | 0.010 |
Why?
|
Regression Analysis | 1 | 2007 | 6329 | 0.010 |
Why?
|
Nucleic Acid Hybridization | 2 | 1989 | 1305 | 0.010 |
Why?
|
Artifacts | 1 | 2005 | 1896 | 0.010 |
Why?
|
Aged | 5 | 2007 | 171343 | 0.010 |
Why?
|
Cell Polarity | 1 | 1999 | 637 | 0.010 |
Why?
|
Intelligence | 1 | 2001 | 925 | 0.010 |
Why?
|
Blotting, Western | 1 | 2003 | 5022 | 0.010 |
Why?
|
NF-kappa B | 1 | 2003 | 2493 | 0.010 |
Why?
|
Oligopeptides | 1 | 2000 | 1195 | 0.010 |
Why?
|
Cross-Sectional Studies | 2 | 2009 | 26310 | 0.010 |
Why?
|
Massachusetts | 1 | 2008 | 8891 | 0.010 |
Why?
|
Temperature | 1 | 2001 | 2233 | 0.010 |
Why?
|
Calcinosis | 1 | 2003 | 1480 | 0.010 |
Why?
|
Epitopes | 1 | 2000 | 2526 | 0.010 |
Why?
|
Microscopy, Fluorescence | 1 | 2001 | 2629 | 0.010 |
Why?
|
Human Growth Hormone | 1 | 1999 | 640 | 0.010 |
Why?
|
Autoimmune Diseases | 1 | 1986 | 2254 | 0.010 |
Why?
|
Polymerase Chain Reaction | 1 | 2003 | 6066 | 0.010 |
Why?
|
Magnetic Resonance Imaging | 1 | 2000 | 36567 | 0.010 |
Why?
|
Protein Processing, Post-Translational | 1 | 2000 | 1964 | 0.010 |
Why?
|
Age Factors | 1 | 2009 | 18397 | 0.010 |
Why?
|
Neuroblastoma | 1 | 2000 | 1266 | 0.010 |
Why?
|
Proportional Hazards Models | 1 | 2007 | 12534 | 0.010 |
Why?
|
Glucocorticoids | 1 | 2001 | 2158 | 0.010 |
Why?
|
Cell Proliferation | 1 | 2007 | 10445 | 0.010 |
Why?
|
Gene Expression Regulation, Neoplastic | 1 | 2007 | 8621 | 0.010 |
Why?
|
Acute Disease | 1 | 1982 | 7241 | 0.010 |
Why?
|
Ubiquitin-Protein Ligases | 1 | 2000 | 1899 | 0.010 |
Why?
|
Severity of Illness Index | 1 | 2009 | 15908 | 0.010 |
Why?
|
Aging | 1 | 2009 | 8731 | 0.010 |
Why?
|
Bacterial Proteins | 1 | 2003 | 3833 | 0.010 |
Why?
|
Oxygen | 1 | 2001 | 4251 | 0.010 |
Why?
|
Adenocarcinoma | 1 | 2007 | 6359 | 0.010 |
Why?
|
Thymidine Kinase | 1 | 1989 | 286 | 0.010 |
Why?
|
Prevalence | 1 | 2006 | 15835 | 0.000 |
Why?
|
Cell Line, Tumor | 1 | 2006 | 17088 | 0.000 |
Why?
|
Swine | 1 | 1999 | 5987 | 0.000 |
Why?
|
T-Lymphocytes | 1 | 1986 | 10264 | 0.000 |
Why?
|
Peptides | 1 | 2000 | 4344 | 0.000 |
Why?
|
Coronary Disease | 1 | 2003 | 5915 | 0.000 |
Why?
|
Mitochondria | 1 | 2001 | 3677 | 0.000 |
Why?
|
Neoplasm Staging | 1 | 2003 | 11218 | 0.000 |
Why?
|
Genetic Predisposition to Disease | 1 | 2009 | 18075 | 0.000 |
Why?
|
Multivariate Analysis | 1 | 2001 | 12064 | 0.000 |
Why?
|
Thyroglobulin | 1 | 1986 | 111 | 0.000 |
Why?
|
Smoking | 1 | 2003 | 9077 | 0.000 |
Why?
|
Mass Screening | 1 | 1981 | 5454 | 0.000 |
Why?
|
Cohort Studies | 1 | 2006 | 41710 | 0.000 |
Why?
|
Postpartum Period | 1 | 1990 | 1195 | 0.000 |
Why?
|
Thyroxine-Binding Proteins | 1 | 1982 | 24 | 0.000 |
Why?
|
Histocompatibility Antigens Class II | 1 | 1986 | 1442 | 0.000 |
Why?
|
Follow-Up Studies | 1 | 2003 | 39309 | 0.000 |
Why?
|
Adolescent | 1 | 2007 | 88904 | 0.000 |
Why?
|
Genetic Vectors | 1 | 1989 | 3401 | 0.000 |
Why?
|
Autoantibodies | 1 | 1986 | 2115 | 0.000 |
Why?
|
Cardiovascular Diseases | 1 | 2003 | 15657 | 0.000 |
Why?
|
Flow Cytometry | 1 | 1986 | 5890 | 0.000 |
Why?
|
India | 1 | 1981 | 2335 | 0.000 |
Why?
|
Child | 1 | 2001 | 80668 | 0.000 |
Why?
|
Antibodies, Monoclonal | 1 | 1986 | 9244 | 0.000 |
Why?
|
Cost-Benefit Analysis | 1 | 1981 | 5536 | 0.000 |
Why?
|